ArticleThe Prostate2009
EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.
Alyse M DeHaan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it